Low levels of replicating Epstein-Barr viruses might be the main driver of the autoimmune condition multiple sclerosis. This may mean that targeting them would be as effective as suppressing the ...

A two-antibody cocktail that targets Nipah and Hendra’s receptor-binding and fusion proteins protects animals from lethal ...

Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure. Subscribe to our ...

Trials are beginning on several drugs that have shown promise in preliminary studies against the virus that is causing the current outbreak. A health worker in the town of Mongbwalu, Democratic ...

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers successfully suppressed the virus in mice and discovered a way to kill infected cells ...

SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...

But it has been hard to attract interest in medical interventions for viruses that have not been considered a top public health priority, scientists say. By Emily Anthes The deadly hantavirus outbreak ...

Treatment with bepirovirsen, an antisense oligonucleotide targeting hepatitis B virus (HBV) transcripts, has the potential to result in a functional cure, defined by at least 24 weeks of a sustained ...